Qube Research & Technologies LTD Fulcrum Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.98 - $9.31 $1.02 Million - $1.58 Million	-169,856 Reduced 23.49%	553,307 $3.43 Million
Q1 2024 May 14, 2024	BUY	$6.7 - $12.0 $3.22 Million - $5.76 Million	480,255 Added 197.71%	723,163 $6.83 Million
Q4 2023 Feb 13, 2024	BUY	$3.18 - $6.86 $730,897 - $1.58 Million	229,842 Added 1759.08%	242,908 $1.64 Million
Q3 2023 Nov 13, 2023	BUY	$3.25 - $6.08 $42,464 - $79,441	13,066 New	13,066 $58,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $133,614 - $763,512	31,813 New	31,813 $156,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.